Veramyst
Pricing Report NDC 0173-0753-00
Current Package Pricing Information
The latest wholesale acquisition cost for Veramyst (NDC 0173-0753-00) is $17.95963 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 20, 2016.
As a provided by Glaxosmithkline Llc, this medication is distributed in a 1 BOTTLE, PUMP in 1 CARTON / 120 SPRAY, METERED in 1 BOTTLE, PUMP configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.
NADAC Pricing Summary
NADAC pricing snapshot for this package NDC
Acquisition Cost $17.95963 Per GM
The NADAC was calculated based on package size.
Historical Pricing Trends & Acquisition Cost Benchmarks
Since Mar 2013, the NADAC wholesale price for (NDC ) has moved within a range of $10.80819 to $18.15277 per GM. Over this 3 years and 3 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.
$10.8082 - $18.1528
67.95% Variance
1.06%
| Date | Unit Price | Unit | Source | Method | Rate |
|---|---|---|---|---|---|
| Jul 20, 2016 | $17.95963 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5 | B - Brand |
| Jul 20, 2016 | $17.95963 | GM | C/I - Chain or Independent Pharmacy | Code 2, 5 | B - Brand |
| Jul 20, 2016 | $17.95963 | GM | C/I - Chain or Independent Pharmacy | Code 4, 5 | B - Brand |
| Jan 01, 2016 | $18.15277 | GM | C/I - Chain or Independent Pharmacy | Code 2, 5 | B - Brand |
| Jan 01, 2016 | $18.15277 | GM | C/I - Chain or Independent Pharmacy | Code 3, 5 | B - Brand |
| Jul 01, 2015 | $15.78474 | GM | C/I - Chain or Independent Pharmacy | Code 2, 5 | B - Brand |
| Jul 01, 2015 | $15.78474 | GM | C/I - Chain or Independent Pharmacy | Code 3, 5 | B - Brand |
| Jan 05, 2015 | $14.35003 | GM | C/I - Chain or Independent Pharmacy | Code 2, 5 | B - Brand |
| Jan 05, 2015 | $14.35003 | GM | C/I - Chain or Independent Pharmacy | Code 3, 5 | B - Brand |
| Sep 17, 2014 | $12.47850 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5 | B - Brand |
| Sep 17, 2014 | $12.47850 | GM | C/I - Chain or Independent Pharmacy | Code 2, 5 | B - Brand |
| Jul 18, 2014 | $12.60668 | GM | C/I - Chain or Independent Pharmacy | Code 2, 5 | B - Brand |
| Jul 18, 2014 | $12.60668 | GM | C/I - Chain or Independent Pharmacy | Code 3, 5 | B - Brand |
| Jan 03, 2014 | $11.67242 | GM | C/I - Chain or Independent Pharmacy | Code 2, 5 | B - Brand |
| Jan 03, 2014 | $11.67242 | GM | C/I - Chain or Independent Pharmacy | Code 3, 5 | B - Brand |
| Mar 21, 2013 | $10.80819 | GM | C/I - Chain or Independent Pharmacy | Code 2, 5 | B - Brand |
Pricing Methodology Legend
- Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
- Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
- Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
- Code 4: The NADAC was carried forward from the previous file.
- Code 5: The NADAC was calculated based on package size.
Understanding NADAC Pricing Data
The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.
Important Price Distinction:
The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.
NADAC Pricing Data Last Updated on: July 08, 2026
